Author

E. Babaeva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

B. Freie· 2 shared H. Mathsyaraja· 2 shared P.-F. Cheng· 2 shared R. N. Eisenman· 2 shared S. Henikoff· 2 shared A. Koehne· 1 shared A. M. Houghton· 1 shared B. K. Hadland· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Freie

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Chromatin Profiling of CBFA2T3-GLIS2 AMLs Identifies Key Transcription Factor Dependencies and BRG1 Inhibition as a Novel Therapeutic Strategy

S. Kaonis, J. L. Smith, N. Katiyar, M. Merrill, T. Hylkema, S. Namciu, Q. Le, E. Babaeva, T. Ikeda, S. M. Morris, E. Girard, S. Furuyama, R. Ries, I. Bernstein, S. Meshinchi, , J. F. Sarthy

This study identifies BRG1 inhibition as a therapeutic strategy for CBFA2T3-GLIS2 AML by analyzing chromatin profiles and CRISPR dependencies.

bioRxiv · Aug 30, 2023 · PreprintCancer Biology

Loss of MGA mediated Polycomb repression promotes tumor progression and invasiveness

H. Mathsyaraja, J. Catchpole, E. Eastwood, E. Babaeva, M. J. Geuenich, P.-F. Cheng, B. Freie, J. L. Ayers, M. Yu, N. Wu, K. R. Poudel, A. Koehne, W. Grady, A. M. Houghton, Y. Shiio, , R. N. Eisenman

This study shows that loss of MGA promotes tumor growth and invasiveness by de-repressing Polycomb targets in lung and colon cancers.

eLife · Jul 8, 2021Peer-reviewedCancer Biology

Max deletion destabilizes MYC protein and abrogates Eμ-Myc lymphomagenesis

H. Mathsyaraja, B. Freie, P.-F. Cheng, E. Babaeva, D. Janssens, S. Henikoff, R. N. Eisenman

The paper shows that deleting Max reduces MYC protein levels and prevents Eμ-Myc lymphomagenesis, but has minimal effect on B-cell development.

bioRxiv · Feb 21, 2019Cancer Biology